Home » Stocks » Medtronic

Medtronic plc. (MDT)

Stock Price: $103.16 USD 1.89 (1.87%)
Updated Sep 25, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 138.67B
Revenue (ttm) 27.93B
Net Income (ttm) 4.41B
Shares Out 1.34B
EPS (ttm) 3.26
PE Ratio 31.64
Forward PE 25.06
Dividend $2.32
Dividend Yield 2.25%

Stock Quote

Trading Day Sep 25, 2020
Last Price $103.16
Previous Close $101.27
Change ($) 1.89
Change (%) 1.87%
Day's Open 100.88
Day's Range 100.30 - 103.65
Day's Volume 3,662,061
52-Week Range 72.13 - 122.15

More Stats

Market Cap 138.67B
Enterprise Value 154.35B
Earnings Date (est) Nov 24, 2020
Ex-Dividend Date Sep 24, 2020
Shares Outstanding 1.34B
Float 1.34B
EPS (basic) 3.29
EPS (diluted) 3.26
FCF / Share 3.54
Dividend $2.32
Dividend Yield 2.25%
Earnings Yield 3.16%
FCF Yield 3.43%
Payout Ratio n/a
Shares Short 6.30M
Short Ratio 1.29
Short % of Float 0.47%
Beta 0.69
PE Ratio 31.64
Forward PE 25.06
P/FCF Ratio 29.16
PS Ratio 4.97
PB Ratio 2.71
Revenue 27.93B
Operating Income 3.98B
Net Income 4.41B
Free Cash Flow 4.76B
Net Cash -15.68B
Net Cash / Share -11.66
Gross Margin 70.36%
Operating Margin 14.25%
Profit Margin 15.80%
FCF Margin 17.03%
ROA 2.83%
ROE 8.76%
ROIC 9.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (25)

Buy 17
Overweight 2
Hold 6
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$117.73*
(14.12% upside)
Low
110
Current: $103.16
High
130
Target: 117.73
*Average 12-month price target from 22 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue28,91330,55729,95329,71028,83320,26117,00516,59016,18415,508
Revenue Growth-5.38%2.02%0.82%3.04%42.31%19.15%2.5%2.51%4.36%-
Gross Profit19,48921,40220,88620,41619,69113,95212,67212,46412,29511,808
Operating Income4,7916,2686,6405,3835,3613,7663,8134,4024,2943,942
Net Income4,7894,6313,1044,0283,5382,6753,0653,4673,6173,096
Shares Outstanding1,3411,3461,3571,3791,4101,0961,0021,0191,0541,077
Earnings Per Share3.543.412.272.892.482.413.023.373.412.86
EPS Growth3.81%50.22%-21.45%16.53%2.9%-20.2%-10.39%-1.17%19.23%-
Dividend Per Share2.162.001.841.721.521.221.121.040.970.90
Dividend Growth8%8.7%6.98%13.16%24.59%8.93%7.69%7.22%7.78%-
Operating Cash Flow7,2347,0074,6846,8805,2184,9024,9594,9424,4703,741
Capital Expenditures-1,213-1,134-1,068-1,254-1,046-571-396-457-484-501
Free Cash Flow6,0215,8733,6165,6264,1724,3314,5634,4853,9863,240
Cash & Equivalents10,9489,84811,22713,70812,63419,48014,24111,1309,3502,428
Total Debt24,79725,32425,75733,44131,10236,18611,92810,65110,6339,835
Net Cash / Debt-13,849-15,476-14,530-19,733-18,468-16,7062,313479-1,283-7,407
Assets90,68989,69491,39399,85799,644106,68537,94334,90032,81830,675
Liabilities39,81739,48240,57149,52747,58153,45518,50016,22915,70514,707
Book Value50,73750,09150,72050,20852,06353,23019,44318,67117,11315,968
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Medtronic plc.
Country Ireland
Employees 90,000
CEO Geoffrey Straub Martha

Stock Information

Ticker Symbol MDT
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: MDT

Description

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.